BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Net Current Assets History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹32 Cr | ₹33 Cr | ₹40 Cr | ₹41 Cr | ₹29 Cr |
What is the latest Net Current Assets ratio of BAFNA PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹32 Cr |
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹40 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹29 Cr |
How is Net Current Assets of BAFNA PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹32 Cr | -1.26 | |
| Mar2025 | ₹33 Cr | -17.16 | |
| Mar2024 | ₹40 Cr | -2.81 | |
| Mar2023 | ₹41 Cr | 41.46 | |
| Mar2022 | ₹29 Cr | - | |
Compare Net Current Assets of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹1,087.8 Cr | 4.6% | 12.4% | 165.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 4.6% |
12.4% |
165.6% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses